rxstatShortages › Raloxifene

Raloxifene shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Raloxifene products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
Products affected
1 / 6
In shortage since
Mar 12, 2026
Est. full return
Jul 31, 2026
Reports on file
14
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
JAMP RALOXIFENE
60MG · TABLET · JAMP PHARMA CORPORATION
DIN 02540681 · since Mar 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Discontinued
EVISTA
60MG · TABLET · ELI LILLY CANADA INC
DIN 02239028
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended May 20, 2025 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Aug 17, 2023 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-RALOXIFENE
60MG · TABLET · APOTEX INC
DIN 02279215 · ended Apr 20, 2023 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Apr 20, 2022 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended May 5, 2021 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Dec 2, 2020 · Disruption of the manufacture of the drug.
Resolved
ACT RALOXIFENE
60MG · TABLET · TEVA CANADA LIMITED
DIN 02358840 · ended Nov 25, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-RALOXIFENE
60MG · TABLET · APOTEX INC
DIN 02279215 · ended Oct 30, 2020 · Disruption of the manufacture of the drug.
Resolved
RALOXIFENE
60MG · TABLET · PRO DOC LIMITEE
DIN 02415852 · ended May 30, 2018 · Other (Please describe in comments)

Showing 12 of 14 reports. All reports are on file with Health Canada.

What's happening

Raloxifene is currently affected by an active shortage report filed with Health Canada by JAMP PHARMA CORPORATION.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Raloxifene is classified under “OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM” (ATC G03XC).

Recent changes

Common questions

When will Raloxifene be back in stock in Canada?

The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Raloxifene in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other sex horm. & modulators of the genital system)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.